One study reported high expression of EGFR to be inversely correlated with nodal metastases and shorter, distant disease-free survival in a group of breast cancer patients who had received 2 years of adjuvant tamoxifen treatment (Dihge et al, 2008). The gene discussed is EGFR; the disease is breast carcinoma.